Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rizwan Romee

Showing results (61-70 of 142) with videos related to

Pageof 15
Sort By:
Blood Advances|May 8, 2023
Posttransplant cyclophosphamide vs tacrolimus-based GVHD prophylaxis: lower incidence of relapse and chronic GVHDKatie Maurer, Vincent T Ho, Eno Inyang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 4, 2015
Hematologic Recovery after Pretransplant Chemotherapy Does Not Influence Survival after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia PatientsKhoan Vu, Shivaprasad Manjappa, John F DiPersio, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2016
Severe Cytokine-Release Syndrome after T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti-IL-6 Therapy Is Safe and Well ToleratedRamzi Abboud, Jesse Keller, Michael Slade, et al.
Nature Communications|October 8, 2025
Selective HLA knockdown and PD-L1 expression prevent allogeneic CAR-NK cell rejection and enhance safety and anti-tumor responses in xenograft miceFuguo Liu, Mubin Tarannum, Yingjie Zhao, et al.
Blood Advances|May 22, 2023
Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapseRoman M Shapiro, Haesook T Kim, Michela Ansuinelli, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Preventing NK cell activation in the damaged liver induced by cabozantinib/PD-1 blockade increases survival in hepatocellular carcinoma modelsSatoru Morita, Hiroto Kikuchi, Grace Birch, et al.
Blood Advances|January 3, 2023
Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cellsKatie Maurer, Haesook T Kim, Heather M Garrity, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2022
Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemiaHan Dong, James Dongjoo Ham, Guangan Hu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2019
Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell TransplantationClinton Lewis, Haesook T Kim, Lindsey E Roeker, et al.
American Journal of Hematology|June 13, 2025
Poor Engraftment After Posttransplant Cyclophosphamide Graft-Versus-Host DISAESE Prophylaxis in Patients With MyelofibrosisHaesook T Kim, Deborah J Liney, Kristen Rizza, et al.
Pageof 15

Showing results (61-70 of 142) with videos related to

Sort By:
Pageof 15
Blood Advances|May 8, 2023
Posttransplant cyclophosphamide vs tacrolimus-based GVHD prophylaxis: lower incidence of relapse and chronic GVHDKatie Maurer, Vincent T Ho, Eno Inyang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 4, 2015
Hematologic Recovery after Pretransplant Chemotherapy Does Not Influence Survival after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia PatientsKhoan Vu, Shivaprasad Manjappa, John F DiPersio, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2016
Severe Cytokine-Release Syndrome after T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti-IL-6 Therapy Is Safe and Well ToleratedRamzi Abboud, Jesse Keller, Michael Slade, et al.
Nature Communications|October 8, 2025
Selective HLA knockdown and PD-L1 expression prevent allogeneic CAR-NK cell rejection and enhance safety and anti-tumor responses in xenograft miceFuguo Liu, Mubin Tarannum, Yingjie Zhao, et al.
Blood Advances|May 22, 2023
Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapseRoman M Shapiro, Haesook T Kim, Michela Ansuinelli, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Preventing NK cell activation in the damaged liver induced by cabozantinib/PD-1 blockade increases survival in hepatocellular carcinoma modelsSatoru Morita, Hiroto Kikuchi, Grace Birch, et al.
Blood Advances|January 3, 2023
Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cellsKatie Maurer, Haesook T Kim, Heather M Garrity, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2022
Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemiaHan Dong, James Dongjoo Ham, Guangan Hu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2019
Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell TransplantationClinton Lewis, Haesook T Kim, Lindsey E Roeker, et al.
American Journal of Hematology|June 13, 2025
Poor Engraftment After Posttransplant Cyclophosphamide Graft-Versus-Host DISAESE Prophylaxis in Patients With MyelofibrosisHaesook T Kim, Deborah J Liney, Kristen Rizza, et al.
Pageof 15